Hening Lin to Lymphoma, Large B-Cell, Diffuse
This is a "connection" page, showing publications Hening Lin has written about Lymphoma, Large B-Cell, Diffuse.
Connection Strength
1.003
-
A Mitochondria-Targeting SIRT3 Inhibitor with Activity against Diffuse Large B Cell Lymphoma. J Med Chem. 2024 09 12; 67(17):15428-15437.
Score: 0.727
-
Translational Activation of ATF4 through Mitochondrial Anaplerotic Metabolic Pathways Is Required for DLBCL Growth and Survival. Blood Cancer Discov. 2022 01; 3(1):50-65.
Score: 0.150
-
Non-oncogene Addiction to SIRT3 Plays a Critical Role in Lymphomagenesis. Cancer Cell. 2019 06 10; 35(6):916-931.e9.
Score: 0.127